Analyst Interview – Stratec Biomedical

Analyst Interview – Stratec Biomedical

Stratec Biomedical designs and manufactures sophisticated automated instruments and software for global companies like DiaSorin, Abbott and Siemens. It is rooted in long-term relationships (68.6% of 2012 revenues were from four customers), growing profits over 10-15-year product life cycles with an installed base of perhaps 12,000 units generating service part revenues. Sales have grown at an average of 20% per year since the 1998 IPO.


You may also be interested in these:

Healthcare

Herantis Pharma – executive interview

Investment Companies

Finsbury Growth & Income Trust – equity proposition